Page 8 - Boca Exposure - October '19

Page 8, Boca Exposure
Susan G. Komen Unveils
®

$26 Million Investment In Research

Susan G. Komen , the world’s leading breast cancer Among the 60 grants Komen awarded, 38 are focused on These new funds bring Komen’s total research investment
®
organization, today announced $26 million in funding for better understanding and treating metastatic breast cancer. in breast cancer to more than $1 billion since opening
new research projects that focus on metastatic breast cancer, Grants were also given to researchers who are developing its doors in 1982, and Komen’s investment in research
developing new, more effective treatments, and addressing new therapies for breast cancer including aggressive subtypes focused on metastatic breast cancer to $210 million. Since
disparities in breast cancer outcomes. This year’s grant slate such as triple negative breast cancer, investigating drug our inception, we have funded more breast cancer research
focuses on key areas that will help the organization achieve resistance, and addressing health disparities in breast cancer than any other nonprofit outside of the U.S. government. In
its bold goal to reduce the current number of breast cancer outcomes among specific communities. addition to research, Komen and its nationwide network of
deaths in the United States by 50 percent by 2026. “Breast cancer does not affect everyone equally and with affiliates serve women and men in thousands of communities.
“In order to save more lives, we must address the main the grants we’re funding this year, we’re moving closer to To date, more than $2.3 billion has been invested in efforts
cause of breast cancer deaths: metastatic breast cancer,” new therapies for aggressive forms of cancer, understanding to provide critical education and real-time support to people
said George Sledge, Susan G. Komen’s co-chief Scientific why treatment doesn’t work in some patients and making in communities across the country.
Advisor, M.D., Professor of Medicine, and Chief of the sure everyone has access to the care they need,” said Paula
Division of Oncology in the Department of Medicine at Schneider, CEO, Susan G. Komen. Komen’s Investments In Florida
Stanford University. Komen’s research grant program is supported in part by
“We are pleased to be able to support research aimed at Komen’s 2019 Portfolio Includes*: funds raised by the organization’s nationwide network of
preventing breast cancers from metastasizing (spreading) 60 grants totaling $25,689,384. Of these: affiliates. Each year, affiliates contribute at least 25 percent
and developing new, more effective treatments for metastatic 38 grants totaling $17,504,384 are focused on better of local funds raised to research, while the remainder of their
disease,” added Komen’s Co-Chief Scientific Advisor, understanding metastasis – why it occurs and how to prevent funds help provide vital education and real-time support to
Jennifer Pietenpol, Ph.D., Executive Vice President for and treat metastatic breast cancer people facing breast cancer today in their communities.
Research at Vanderbilt University Medical Center, Director 39 grants totaling $15,579,815 for catalyzing the Since 1991, Komen Florida has funded $56.88 million to
of the Vanderbilt-Ingram Cancer Center, the B.F. Byrd development of new therapies for all stages of breast cancer community programs serving local women and men, through
Jr. Professor of Molecular Oncology, and Professor of 16 grants looking into novel treatments for triple negative research, screening, treatment assistance and education.
Biochemistry and Otolaryngology at Vanderbilt University breast cancer
School of Medicine. 14 grants totaling $6,298,750 investigating drug Metastasis Research Society
More than an estimated 154,000 women in the United resistance (why drugs stop working in some patients) The Metastasis Research Society (MRS) will receive
States are living with metastatic breast cancer – the most 9 grants focused on disparities in breast cancer outcomes $23,000 to support collaborative programming at MRS’s 18th
advanced stage of breast cancer that has spread outside the and Biennial Congress. At this conference, researchers will discuss
breast, often to the brain, bones, liver and lungs. Currently, 5 that apply big data technology (e.g. artificial intelligence, the latest experimental and clinical developments about cancer
there is no cure for metastatic breast cancer, and it is machine learning) to breast cancer research metastasis (spread) as well as new opportunities for more
responsible for almost all the 42,000 breast cancer deaths *Editor’s Note: Numbers add to more than 60 because effective treatment strategies. The funding will also support
in the United States each year. individual studies may be classed in more than one category. travel to ensure participation of metastatic breast cancer patient
advocates and early-career breast cancer researchers.
“We are so thankful for the friends, family and neighbors
that fight alongside us, helping to reduce the number of breast
cancer deaths in Florida, both on the ground and through
research,” said Kate Watt, Komen Florida executive director.

About Susan G. Komen®
Susan G. Komen® is the world’s leading nonprofit breast
cancer organization, working to save lives and end breast
cancer forever. Komen has an unmatched, comprehensive
360-degree approach to fighting this disease across all
fronts and supporting millions of people in the United States
and in countries worldwide. We advocate for patients, drive
research breakthroughs, improve access to high-quality
care, offer direct patient support and empower people with
trustworthy information. Born out of a promise between two
sisters, Susan G. Komen remains committed to supporting
those affected by breast cancer today, while tirelessly
searching for tomorrow’s cures.
Grants are contingent upon signed and executed
contracts with Komen.

Medicare SONA T A BOCA RA TON ASSISTED LIVING MEMOR Y CARE

Make Your Own Choices, Find Your Rhythm!
open enrollMent

10/15 - 12/7 For 2020 Plans

review your Plan For
changes and veriFy

all beneFits you are
entitled to

Peter gratzon LUNCH ON US!

toP indePendent
medicare agent Please join us for a visit with
complimentary lunch!*
561-361-7173 • Weekly Outings to Shopping, Restaurants, & Theaters

c: 561-289-9396 • Spacious Gathering Areas For Entertainment Call Today to Reserve Your
Appointment Date and Time:

time for a supplemeNtal plaN? • Executive Chef-Prepared Meals 561-291-6183
choose aNy doctor/hospital/No referrals • Licensed Nurse On Site 24/7
aNywhere iN the couNtry • Onsite Therapy Services *Maximum of three people.
appoiNted with major iNsuraNce carriers Offer ends on 11/15
LEARN MORE AT SONATABOCARATON.COM
No obligatioN/No fees/No commissioN 9591 YAMATO ROAD, BOCA RATON, FL 33434.
call for iN-home appoiNtmeNt ASSISTED LIVING FACILITY LICENSE #9911